Leadership & Management
Novartis appoints Anne Harris as new Country President
Novartis Australia & New Zealand has announced the appointment of ex-Pfizer Managing Director Anne Harris as Country President of Australia […]
MoreLeadership & Management
Leadership transition at Chiesi Australia as Micevski succeeds McGregor as GM
Chiesi Australia’s General Manager, Melissa McGregor, will leave the company at the end of July to focus on the health […]
MoreLeadership & Management
Boards near historic all-male exit yet true diversity remains elusive
Australia’s biggest companies are close to reaching a boardroom milestone, with the end of the all-male ASX 300 board now […]
MoreLeadership & Management
Cardinal Health MD on leadership’s new currency in a ‘decade of disorientation’
As healthcare leaders confront a period of accelerating change, Neroli Manning, Managing Director of Cardinal Health ANZ, joins the Health […]
MoreLeadership & Management
Rising trade-offs and trust fractures: Novartis President decodes shifting rules of leadership
As pressure builds across policy, innovation and public expectation, Ali Rossiter, Country President, Novartis ANZ, joins the Health Industry Hub […]
MoreLeadership & Management
Roche Diagnostics MD decodes ‘grounded leader’ playbook amid escalating complexity
Navigating a health system under intensifying pressure and accelerating uncertainty, Anand Vairavan, Managing Director of Roche Diagnostics Australia joins this […]
MoreLeadership & Management
Amgen GM unpacks AI, cultural nuance and pressures reshaping leadership
The rules of leadership are being rewritten in real time as a complex national and geopolitical landscape continues to challenge […]
MoreLeadership & Management
Pfizer names vaccines head as ANZ interim Managing Director
Pfizer has appointed Ben Fitzsimmons as Interim Managing Director for Australia and New Zealand, effective 4 May 2026. He takes […]
MoreLeadership & Management
Boehringer GM on trust, turbulence and leading in motion
Ed Hollywood, General Manager of Boehringer Ingelheim ANZ, joins Health Industry Hub’s senior leadership podcast series in a conversation that […]
MoreLeadership & Management
Moderna appoints founding member Dr Tucek-Szabo to steer ANZ business
Carolyn Tucek-Szabo has been appointed General Manager for Moderna Australia and New Zealand, succeeding Michael Azrak, who has transitioned to […]
MoreRecent Posts in Pharma, MedTech & Biotech
David Henderson appointed Takeda Oceania Country Head
August 10, 2026
in Leadership & Management
GBMA puts medicine shortages on the table as strategic agreement talks begin
August 10, 2026
in News - Pharmaceuticals
Australia sets a new course for prostate cancer detection
August 10, 2026
in News - MedTech & Diagnostics
IVF success rates climb as ART sector faces major accreditation overhaul
August 10, 2026
in News - Pharmaceuticals
‘Get comfortable being uncomfortable,’ urges Medtronic VP and Managing Director
August 7, 2026
in News - MedTech & Diagnostics
Department of Health halts PL changes as industry warns of device viability
August 7, 2026
in News - MedTech & Diagnostics
argenx inks new agreement with Australian regenerative medicine biotech
August 7, 2026
in News - Biotechnology
The human faces rewriting Australia’s most common rare disease, cystic fibrosis
August 7, 2026
in News - Pharmaceuticals
Follow Us
Partner with us
Leadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
MoreNews - Pharmaceuticals
GBMA puts medicine shortages on the table as strategic agreement talks begin
As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]
MoreNews - MedTech & Diagnostics
Australia sets a new course for prostate cancer detection
Australia has become one of the first countries in the world to adopt a modern, evidence-based framework for the early […]
MoreNews - Pharmaceuticals
IVF success rates climb as ART sector faces major accreditation overhaul
Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]
More